Literature DB >> 30415786

Implementing statistical methods for generalizing randomized trial findings to a target population.

Benjamin Ackerman1, Ian Schmid2, Kara E Rudolph3, Marissa J Seamans2, Ryoko Susukida4, Ramin Mojtabai2, Elizabeth A Stuart5.   

Abstract

Randomized trials are considered the gold standard for assessing the causal effects of a drug or intervention in a study population, and their results are often utilized in the formulation of health policy. However, there is growing concern that results from trials do not necessarily generalize well to their respective target populations, in which policies are enacted, due to substantial demographic differences between study and target populations. In trials related to substance use disorders (SUDs), especially, strict exclusion criteria make it challenging to obtain study samples that are fully "representative" of the populations that policymakers may wish to generalize their results to. In this paper, we provide an overview of post-trial statistical methods for assessing and improving upon the generalizability of a randomized trial to a well-defined target population. We then illustrate the different methods using a randomized trial related to methamphetamine dependence and a target population of substance abuse treatment seekers, and provide software to implement the methods in R using the "generalize" package. We discuss several practical considerations for researchers who wish to utilize these tools, such as the importance of acquiring population-level data to represent the target population of interest, and the challenges of data harmonization.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  External validity; Generalizability; Randomized trials; Statistics

Mesh:

Substances:

Year:  2018        PMID: 30415786      PMCID: PMC6483886          DOI: 10.1016/j.addbeh.2018.10.033

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  21 in total

1.  Beyond efficacy: the STAR*D trial.

Authors:  Thomas R Insel
Journal:  Am J Psychiatry       Date:  2006-01       Impact factor: 18.112

2.  Selection criteria and generalizability within the counterfactual framework: explaining the paradox of antidepressant-induced suicidality?

Authors:  Herbert I Weisberg; Vanessa C Hayden; Victor P Pontes
Journal:  Clin Trials       Date:  2009-04       Impact factor: 2.486

3.  The influence of patients' preference/attitude towards psychotherapy and antidepressant medication on the treatment of major depressive disorder.

Authors:  Latif Moradveisi; Marcus Huibers; Fritz Renner; Arnoud Arntz
Journal:  J Behav Ther Exp Psychiatry       Date:  2013-10-15

Review 4.  A Comprehensive Literature Review of Randomized Controlled Trials for Parents of Young Children with Autism Spectrum Disorder.

Authors:  Sarah Dababnah; Susan L Parish
Journal:  J Evid Inf Soc Work       Date:  2015-07-15

5.  Estimating population treatment effects from a survey subsample.

Authors:  Kara E Rudolph; Iván Díaz; Michael Rosenblum; Elizabeth A Stuart
Journal:  Am J Epidemiol       Date:  2014-09-04       Impact factor: 4.897

Review 6.  Efficacy and effectiveness trials (and other phases of research) in the development of health promotion programs.

Authors:  B R Flay
Journal:  Prev Med       Date:  1986-09       Impact factor: 4.018

7.  Generalizing evidence from randomized clinical trials to target populations: The ACTG 320 trial.

Authors:  Stephen R Cole; Elizabeth A Stuart
Journal:  Am J Epidemiol       Date:  2010-06-14       Impact factor: 4.897

Review 8.  Large-scale randomized evidence: large, simple trials and overviews of trials.

Authors:  R Peto; R Collins; R Gray
Journal:  J Clin Epidemiol       Date:  1995-01       Impact factor: 6.437

9.  Topiramate for treating alcohol dependence: a randomized controlled trial.

Authors:  Bankole A Johnson; Norman Rosenthal; Julie A Capece; Frank Wiegand; Lian Mao; Karen Beyers; Amy McKay; Nassima Ait-Daoud; Raymond F Anton; Domenic A Ciraulo; Henry R Kranzler; Karl Mann; Stephanie S O'Malley; Robert M Swift
Journal:  JAMA       Date:  2007-10-10       Impact factor: 56.272

10.  Assessing sample representativeness in randomized controlled trials: application to the National Institute of Drug Abuse Clinical Trials Network.

Authors:  Ryoko Susukida; Rosa M Crum; Elizabeth A Stuart; Cyrus Ebnesajjad; Ramin Mojtabai
Journal:  Addiction       Date:  2016-04-01       Impact factor: 6.526

View more
  4 in total

1.  Recruitment Challenges for Low-Risk Health System Intervention Trials in Older Adults: A Case Study.

Authors:  Kathryn Anzuoni; Terry S Field; Kathleen M Mazor; Yanhua Zhou; Lawrence D Garber; Alok Kapoor; Jerry H Gurwitz
Journal:  J Am Geriatr Soc       Date:  2020-07-25       Impact factor: 5.562

2.  Target validity: Bringing treatment of external validity in line with internal validity.

Authors:  Catherine R Lesko; Benjamin Ackerman; Michael Webster-Clark; Jessie K Edwards
Journal:  Curr Epidemiol Rep       Date:  2020-06-30

3.  Land tenure drives Brazil's deforestation rates across socio-environmental contexts.

Authors:  Andrea Pacheco; Carsten Meyer
Journal:  Nat Commun       Date:  2022-10-01       Impact factor: 17.694

4.  Applicability of evidence from randomized controlled trials and systematic reviews to clinical practice: A conceptual review.

Authors:  Antti Malmivaara
Journal:  J Rehabil Med       Date:  2021-05-11       Impact factor: 2.912

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.